Airway 5 mg (Tablet)
Medicine Details
Category | Details |
---|---|
Generic | Montelukast sodium |
Company | One pharma ltd |
Also available as |
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
Montelukast is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene receptor (CysLT1).
Dosage & Administration
- 10 mg tablet once daily for adults and adolescents 15 years of age and older
- 5 mg tablet once daily for pediatric patients 6 to 14 years of age
- 4 mg tablet or oral granules once daily for pediatric patients 2 to 5 years of age
- 4 mg oral granules once daily for pediatric patients 6 months to 5 years of age
Hepatic Insufficiency
No dosage adjustment is required in patients with mild-to-moderate hepatic insufficiency.
Renal Insufficiency
No dosage adjustment is recommended in patients with renal insufficiency.
Elderly use
The pharmacokinetic profile and the oral bioavailability of a single 10-mg oral dose of montelukast are similar in elderly and younger adults.
Interaction
Airway has been administered with other therapies routinely used in the prophylaxis and chronic treatment of asthma with no apparent increase in adverse reactions.
Contraindications
Montelukast is contraindicated in patients who are hypersensitive to any component of this product.
Side Effects
- Diarrhoea
- Fever
- Gastrointestinal discomfort
- Headache
- Nausea
- Vomiting
- Skin reactions
- Upper respiratory tract infection
- Akathisia
- Anxiety
- Arthralgia
- Asthenia
- Abnormal behavior
- Depression
- Dizziness
- Drowsiness
- Dry mouth
- Haemorrhage
- Irritability
- Malaise
- Muscle complaints
- Oedema
- Seizure
- Abnormal sensation
- Sleep disorders
- Angioedema
- Concentration impaired
- Disorientation
- Eosinophilic granulomatosis with polyangiitis
- Erythema nodosum
- Hallucination
- Hepatic disorders
- Memory loss
- Palpitations
- Pulmonary eosinophilia
- Suicidal tendencies
- Tremor
Pregnancy & Lactation
Montelukast crosses the placenta following oral dosing in rats and rabbits. Caution should be exercised when Montelukast is given to a nursing mother.
Precautions & Warnings
Airway is not indicated for use in the reversal of bronchospasm in acute asthma attacks.
Overdose Effects
The most frequently occurring adverse experiences included abdominal pain, somnolence, thirst, headache, vomiting, and psychomotor hyperactivity.
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture.
Chemical Structure
- Molecular Formula: C35H36ClNO3S
- Chemical Structure Image URL: https://medex.com.bd/storage/res/g-res-768-montelukast-sodium-chemical-structure-drK1lRHjspWQ7613gJoZ.svg
Common Questions about Airway 5 mg Tablet
- Selective and orally active leukotriene receptor antagonist
- Used to treat asthma or allergic rhinitis
- Effect can be observed after 1-3 hours of administration
- Effect lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by a doctor
- Use in pregnant women should be avoided unless clearly needed
General Instructions
- Take Airway exactly as prescribed by a doctor
- Do not change the dose or stop using asthma medication without a doctor's advice
- Seek medical attention if breathing problems get worse quickly or if medications are not working
- Avoid situations or activities that may trigger an asthma attack
- Talk to a doctor before using Airway if pregnant or breastfeeding
Related Brands
- Aeron FT 4 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron FT 5 mg (Dispersible Tablet) - healthcare-pharmaceuticals-ltd
- Aeron 10 mg (Tablet) - healthcare-pharmaceuticals-ltd
- Montinex 4 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Montinex 5 mg (Chewable Tablet) - beacon-pharmaceuticals-plc